QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy
Trial details
- Registry ID
- NCT03853317
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ALT-803; Anktiva; also known as IL-15N72D:IL-15RαSu/IgG1 Fc complex]), ALT-803
| No regulatory events match this view.This does not mean no FDA events have occurred. |